Flu vaccine strains endorsed by FDA panel for 2013-2014

03/8/2013 | Medscape (free registration)

The FDA's Vaccines and Related Biological Products Advisory Committee endorsed a slightly different influenza vaccine composition for the 2013-2014 flu season, compared with that of the previous season. The committee recommended substituting two vaccine strains while retaining the A/California/7/2009pdm09-like virus. The committee also released recommendations for quadrivalent vaccines, noting that "global influenza virus surveillance data related to epidemiology and antigenic characteristics, serological responses to 2012-2013 seasonal vaccines, and the availability of candidate strains and reagents" were used as the basis for the recommendations.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA